Source: BIOSPACE

Thrasos: Thrasos To Present At The 22nd Annual NewsMakers And Conferences

MONTREAL--(BUSINESS WIRE)--Thrasos Therapeutics, a biotherapeutics company focused on delivering new solutions for kidney disease, announced today that it will be participating in two key meetings in September, BioCentury NewsMakers and BioPharm America.Richard Andrews President and Chief Executive Officer will present a company overview at the 22nd Annual BioCentury NewsMakers in the...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more